Showing results (11-20 of 115) with videos related to
Sort By:
Pageof 12
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Alizapride alone or alizapride-dexamethasone compared with metoclopramide-dexamethasone in patients at high risk of acute emesis after cisplatin. A randomized cross-over studyC F Pollera, M Nardi, P Marolla, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1994
Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I studyC F Pollera, A Ceribelli, M Crecco, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
A randomized trial comparing alizapride alone or with dexamethasone vs a metoclopramide-dexamethasone combination for emesis induced by moderate-dose cisplatinC F Pollera, M Nardi, P Marolla, et al.Cancer Chemotherapy and Pharmacology|October 11, 2001
Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I studyM Nardi, S De Marco, A Fabi, et al.Journal of Experimental & Clinical Cancer Research : CR|February 15, 2003
Perspectives in the clinical management of BRCA mutations carriersA Savarese, F CognettiJournal of Experimental & Clinical Cancer Research : CR|June 10, 2005
A partial response in anaplastic carcinoma of the thyroid with liposomal doxorubicinL Moscetti, D Padalino, E Capomolla, et al.Investigational New Drugs|January 1, 1997
Prolonged infusion gemcitabine: a clinical phase I study at low- (300 mg/m2) and high-dose (875 mg/m2) levelsC F Pollera, A Ceribelli, M Crecco, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?P Carlini, A Frassoldati, S De Marco, et al.Oncology|January 1, 1987
Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesisC F Pollera, E M Conti, A De Nigris, et al.Journal of Chemotherapy (Florence, Italy)|January 26, 2006
Gemcitabine and cisplatin in the treatment of elderly patients with advanced non-small cell lung cancer: impact of comorbidities on safety and efficacy outcomeL Moscetti, F Nelli, D Padalino, et al.Pageof 12